No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Biopsy
-
Drug Eruptions / diagnosis
-
Drug Eruptions / etiology*
-
Fatal Outcome
-
Humans
-
Indoles / adverse effects*
-
Keratosis
-
Male
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Melanoma / secondary
-
Middle Aged
-
Miliaria / chemically induced*
-
Miliaria / diagnosis
-
Mutation
-
Protein Kinase Inhibitors / adverse effects*
-
Proto-Oncogene Proteins B-raf / genetics
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / genetics
-
Skin Neoplasms / pathology
-
Sulfonamides / adverse effects*
-
Time Factors
-
Treatment Outcome
-
Vemurafenib
Substances
-
Antineoplastic Agents
-
Indoles
-
Protein Kinase Inhibitors
-
Sulfonamides
-
Vemurafenib
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf